StocksMediumUpdated•Originally published 29 September 2026•Updated 30 September 2026•
1 min read
Concentrix Shares Under Pressure After $1B Impairment Charge and Lowered Guidance
Key Facts
1Concentrix reported Non-GAAP EPS of $2.92, beating analyst estimates by $0.22.
2The company's revenue reached $2.45B, missing consensus estimates by $30M.
Concentrix recorded a $1 billion non-cash goodwill impairment charge in the third quarter and lowered its revenue guidance for the full fiscal year 2026. The company reported revenue of $2.45 billion, representing a 1.2% year-over-year decline and missing consensus estimates by $30 million.
The company achieved Non-GAAP earnings per share of $2.92, which beat analyst expectations by $0.22 despite the revenue contraction. CNXC closed at $25.45 on September 28, 2026, with the stock trading between a low of $24.61 and a high of $26.8 during that session prior to the disclosure of the impairment and revised outlook.